Hatschek T - Search Results

1

Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy.

Suzuki C, Blomqvist L, Hatschek T, Carlsson L, Einbeigi Z, Linderholm B, Lindh B, Loman N, Malmberg M, Rotstein S, Söderberg M, Sundqvist M, Walz TM, Aström G, Fujii H, Jacobsson H, Glimelius B. Suzuki C, et al. Among authors: hatschek t. Med Oncol. 2013 Mar;30(1):415. doi: 10.1007/s12032-012-0415-5. Epub 2013 Jan 16. Med Oncol. 2013. PMID: 23322522 Clinical Trial.

2

Radiologic measurements of tumor response to treatment: practical approaches and limitations.

Suzuki C, Jacobsson H, Hatschek T, Torkzad MR, Bodén K, Eriksson-Alm Y, Berg E, Fujii H, Kubo A, Blomqvist L. Suzuki C, et al. Among authors: hatschek t. Radiographics. 2008 Mar-Apr;28(2):329-44. doi: 10.1148/rg.282075068. Radiographics. 2008. PMID: 18349443 Review.

3

Psychological reactions to progression of metastatic breast cancer--an interview study.

Svensson H, Brandberg Y, Einbeigi Z, Hatschek T, Ahlberg K. Svensson H, et al. Among authors: hatschek t. Cancer Nurs. 2009 Jan-Feb;32(1):55-63. doi: 10.1097/01.NCC.0000343374.09270.ff. Cancer Nurs. 2009. PMID: 19104202

4

Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria.

Suzuki C, Torkzad MR, Jacobsson H, Aström G, Sundin A, Hatschek T, Fujii H, Blomqvist L. Suzuki C, et al. Among authors: hatschek t. Acta Oncol. 2010 May;49(4):509-14. doi: 10.3109/02841861003705794. Acta Oncol. 2010. PMID: 20397778

5

Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine).

Svensson H, Einbeigi Z, Johansson H, Hatschek T, Brandberg Y. Svensson H, et al. Among authors: hatschek t. Breast Cancer Res Treat. 2010 Oct;123(3):785-93. doi: 10.1007/s10549-010-1084-8. Epub 2010 Aug 3. Breast Cancer Res Treat. 2010. PMID: 20680680 Clinical Trial.

6

Svensson H, Hatschek T, Johansson H, Einbeigi Z, Brandberg Y. Svensson H, et al. Among authors: hatschek t. Med Oncol. 2012 Jun;29(2):432-8. doi: 10.1007/s12032-011-9844-9. Epub 2011 Feb 6. Med Oncol. 2012. PMID: 21298494 Clinical Trial.

7

Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.

Kimbung S, Kovács A, Bendahl PO, Malmström P, Fernö M, Hatschek T, Hedenfalk I. Kimbung S, et al. Among authors: hatschek t. Mol Oncol. 2014 Feb;8(1):119-28. doi: 10.1016/j.molonc.2013.10.002. Epub 2013 Oct 14. Mol Oncol. 2014. PMID: 24287398 Free PMC article.

8

Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival.

Tobin NP, Harrell JC, Lövrot J, Egyhazi Brage S, Frostvik Stolt M, Carlsson L, Einbeigi Z, Linderholm B, Loman N, Malmberg M, Walz T, Fernö M, Perou CM, Bergh J, Hatschek T, Lindström LS; TEX Trialists Group. Tobin NP, et al. Among authors: hatschek t. Ann Oncol. 2015 Jan;26(1):81-88. doi: 10.1093/annonc/mdu498. Epub 2014 Oct 31. Ann Oncol. 2015. PMID: 25361981 Free PMC article. Clinical Trial.

9

Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer.

Kimbung S, Johansson I, Danielsson A, Veerla S, Egyhazi Brage S, Frostvik Stolt M, Skoog L, Carlsson L, Einbeigi Z, Lidbrink E, Linderholm B, Loman N, Malmström PO, Söderberg M, Walz TM, Fernö M, Hatschek T, Hedenfalk I; TEX study group. Kimbung S, et al. Among authors: hatschek t. Clin Cancer Res. 2016 Jan 1;22(1):146-57. doi: 10.1158/1078-0432.CCR-15-0487. Epub 2015 Aug 14. Clin Cancer Res. 2016. PMID: 26276891

10

Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications.

Kimbung S, Kovács A, Danielsson A, Bendahl PO, Lövgren K, Frostvik Stolt M, Tobin NP, Lindström L, Bergh J, Einbeigi Z, Fernö M, Hatschek T, Hedenfalk I. Kimbung S, et al. Among authors: hatschek t. Oncotarget. 2015 Oct 20;6(32):33306-18. doi: 10.18632/oncotarget.5089. Oncotarget. 2015. PMID: 26375671 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters